Great they get a mention I guess, but really the important thing now for OPL is to move on the revenue front. Articles, interviews, tweets, retweets of articles about AI, conferences, guest speaking - Move out of academia and into business mode please.
Show that the technology can go to market and that firms are interested in and willing to PAY $ not just trialing it for free.
February Market Launch - ??? If it has occured it has been less than impressive.
What happened to the regular webinars?
They have until the end of June Quarter until they will need to be looking at raising capital. Raising capital is much easier and less offensive to the market if you can show the "re-calibration" pivot is gaining traction.
Unless you bought the day the day of the consolidation (29/11/19) occurred where it blipped below the 0.001/0.10 level every single investor in OPL/SRO is underwater - historical lows. Go team.
Ann: Opyl develops clinical trial prediction software using AI, page-18
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
